MifepristoneAbortifacient Agents, SteroidalDrug ApprovalHormone AntagonistsMisoprostolAbortifacient Agents, NonsteroidalContraceptives, Postcoital, SyntheticAbortifacient AgentsAbortion, InducedContraceptives, Oral, SyntheticMenstruation-Inducing AgentsUnited States Food and Drug AdministrationDevice ApprovalLuteolytic AgentsLevonorgestrelAdministration, IntravaginalNorpregnadienesReceptors, GlucocorticoidEndometriumProgesteroneContraceptives, PostcoitalUterine HemorrhageLuteal PhaseContraception, PostcoitalProgestinsContraceptive Agents, FemalePregnancyGonanesCytostatic AgentsMenstruationReceptors, ProgesteroneLabor Stage, FirstPregnancy Trimester, FirstAdministration, SublingualPregnanediolOvulation InhibitionMenstrual CycleDanazolEthics Committees, ResearchMegestrolAlcohol-Induced Disorders, Nervous SystemVacuum CurettageEmbryo ImplantationMetrorrhagiaEthics CommitteesEthical ReviewContraceptives, Postcoital, HormonalOrphan Drug ProductionFallopian TubesAlgestoneGlucocorticoidsNorgestrelOxytocicsUnited StatesProduct Surveillance, PostmarketingAbortion, LegalMenorrhagiaCorticosteronePessariesClostridium sordelliiDexamethasoneDrug IndustryEthinyl EstradiolLeiomyomaClinical Trials as TopicReceptors, Mineralocorticoid